CA-125 levels in predicting optimal cytoreductive surgery in patients with advanced epithelial ovarian carcinoma

被引：11
|
作者：
Alcázar, JL [1 ]
Miranda, D [1 ]
Unanue, A [1 ]
Novoa, E [1 ]
Alemán, S [1 ]
Madariaga, L [1 ]
机构：
[1] Univ Navarra, Sch Med, Univ Navarra Clin, Dept Obstet & Gynecol, E-31080 Pamplona, Spain
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS | 2004年 / 84卷 / 02期
关键词：
CA-125; optimal cytoreduction; advanced ovarian cancer;
D O I：
10.1016/j.ijgo.2003.10.006
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
[No abstract available]
引用
收藏
页码：173 / 174
页数：2
相关论文
共 50 条
  • [1] CA-125 levels as a predictor for optimal cytoreductive surgery in epithelial ovarian cancer
    Modesto Trevino-Salinas, Emilio
    Ayuzo-del Valle, Cipatli
    de Jesus del Angel-Cervantes, Julio
    GACETA MEXICANA DE ONCOLOGIA, 2014, 13 (04): : 203 - 206
  • [2] CA125 levels are a weak predictor of optimal cytoreductive surgery in patients with advanced epithelial ovarian cancer
    Memarzadeh, S
    Lee, SB
    Berek, JS
    Farias-Eisner, R
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2003, 13 (02) : 120 - 124
  • [3] IS CA-125 MONITORING USEFUL IN PATIENTS WITH EPITHELIAL OVARIAN-CARCINOMA AND PREOPERATIVE NEGATIVE CA-125 SERUM LEVELS
    SEVELDA, P
    ROSEN, A
    DENISON, U
    BARRADA, M
    SPONA, J
    SALZER, H
    GYNECOLOGIC ONCOLOGY, 1991, 43 (02) : 154 - 158
  • [4] FDG PET/CT parameters and CA-125 levels to predict optimal cytoreduction at primary cytoreductive surgery for advanced ovarian cancer
    Kim, Junhwan
    Lee, Maria
    Kim, Se Ik
    Gil, Joonhyung
    Kim, Jae-Weon
    Cheon, Gi Jeong
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S91 - S91
  • [5] Can serum CA-125 levels predict the optimal primary cytoreduction in patients with advanced ovarian carcinoma?
    Saygili, U
    Guclu, S
    Uslu, T
    Erten, O
    Demir, N
    Onvural, A
    GYNECOLOGIC ONCOLOGY, 2002, 86 (01) : 57 - 61
  • [6] Preoperative CA-125 levels in patients with hereditary compared to sporadic epithelial ovarian carcinoma
    Leitao, M
    Boyd, J
    GYNECOLOGIC ONCOLOGY, 2002, 84 (03) : 413 - 415
  • [7] Effect of topotecan on serum CA-125 in patients with advanced epithelial ovarian cancer
    Nielsen, HA
    Nielsen, D
    Engelholm, SA
    GYNECOLOGIC ONCOLOGY, 2000, 77 (03) : 383 - 388
  • [8] The role of serum CA-125 levels and CA-125 tissue expression positivity in the prediction of the recurrence of stage III and IV epithelial ovarian tumors (CA-125 levels and tissue CA-125 in ovarian tumors)
    Gundogdu, Fatih
    Soylu, Ferit
    Erkan, Levent
    Tatli, Orkan
    Mavi, Sadiye
    Yavuzcan, Ali
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2011, 283 (06) : 1397 - 1402
  • [9] The role of serum CA-125 levels and CA-125 tissue expression positivity in the prediction of the recurrence of stage III and IV epithelial ovarian tumors (CA-125 levels and tissue CA-125 in ovarian tumors)
    Fatih Gundogdu
    Ferit Soylu
    Levent Erkan
    Orkan Tatli
    Sadiye Mavi
    Ali Yavuzcan
    Archives of Gynecology and Obstetrics, 2011, 283 : 1397 - 1402
  • [10] Preoperative CA-125 level as a predictor of non optimal cytoreduction of advanced epithelial ovarian cancer
    Gemer, O
    Segal, S
    Kopmar, A
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2001, 80 (06) : 583 - 585
12345